{
    "2018-01-29": [
        [
            {
                "time": "",
                "original_text": "医疗保健：羟乙基淀粉替代打开白蛋白成长上限 荐3股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "羟乙基淀粉",
                        "白蛋白",
                        "成长上限"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业政策点评:羟乙基淀粉或将受限,利好国产白蛋白",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策",
                        "羟乙基淀粉",
                        "国产白蛋白"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}